Answers are grounded in this paper and cite their sources.
Aims When indicated Speedboat -Endoscopic Submucosal Dissection/S-ESD is a novel alternative endoscopic procedure that uses innovative modalities to safely and effectively remove pre-cancerous and suspected cancerous complex lesions in the colon, in turn removing the need for surgical interventions and the associated complications, bed stays, resources and costs to the Trust/hospital Methods The aim of this value-based procurement pilot study was to look into the health economic aspect of the S-ESD and surgery approaches. We measured the outcomes on procedural times, hospital length of stay, the need for follow-up hospital visits, the patient pathway and release capacity and costs. Descriptive statistics summaries (mean and standard deviation) of the above variants. Trust’s Patient-Level Information and Costing System (PLICS) at each patient level was used to analyse all activities based on the Trust’s actual costs, using NHS England’s Approved Costing Guidance (ACG). Results 1,000 patients treated for colorectal lesions, have been analysed (130 of those being S-ESD patients) from January 2018 to March 2022. East Kent Hospitals University NHS Foundation Trust (EKHUFT) has produced a dataset of financial and non-financial information. These patients were subject to S-ESD and Surgical procedure. The final evaluation tool enables us to quantify cost savings and productivity gains due to the use of S-ESD compared to surgical procedures. Specifically, the financial and non-financial findings highlighted: i) 25% reduction of theatre time from average 198 minutes to 149 minutes, ii) 87% reduction of length of stay from average of 8.39 days (of which 0.72 intensive care unit/ITU days) to 1.07 days (of which 0.01 ITU days, ii) 38% reduction of theatre procedure cost from £4.5k to £2,8k, iv) 94% reduction of accommodation cost from £3.2k to £0.2k, v) 63% reduction of admission cost from £8.0k to £3.0k, vi) 59% reduction over a 1 year period a cost from £8.6k to £3.5k. [ 1 ] Conclusions This explorative analysis of EKHUFT financial modelling has demonstrated preliminary efficiency benefits through reduced length of stay and improved theatre efficiency have released net benefits of £671k for the 130 S-ESD procedures, which equates to £5.2k per patient. Using this PLICS dataset, a matched pairs propensity analysis is now warranted to ratify these observed cost saving findings. Publication History Article published online: 15 April 2024 © 2024. European Society of Gastrointestinal Endoscopy. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany
No takes yet. Share an insight, caveat, or question.
Zeidan et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: